Whole Exome Sequencing with Infants in the NICU

  • Clinical Presentation:
    • Team consulted an infant-4 days old in the NICU
    • Team decided to order whole exome sequencing based on infant’s presentation
  • BG Test: 
    • Critical Trio WES
  • Results:
    • Two heterozygous c.4965C>G (p.Y1655X) and c.7007G>C (p.R2336P) pathogenic variants in BRCA2 were detected.
    • Defects in BRCA2 are the cause of Fanconi anemia complementation group D1 (FANCD1)
  • Clinical Management After Test:
    • Team arranged treatment and management for an infant with Fanconi anemia
    • Predictive genetic testing for the BRCA2 pathogenic variant available for at risk relatives in order to see if they are at high risk of breast and other BRCA2 related cancers
Menu